Anzavir-R Tablet

Anzavir-R Tablet – Atazanavir (300mg) + Ritonavir (100mg)

Anzavir-R Tablet combines the protease inhibitor Atazanavir 300mg with low-dose Ritonavir 100mg as a pharmacokinetic booster, manufactured by Mylan Pharmaceuticals Pvt Ltd – A Viatris Company. Ritonavir raises and sustains Atazanavir blood levels, allowing effective once-daily protease-inhibitor-based antiretroviral therapy for HIV-1 infection.

Key Features

• Boosted protease-inhibitor combination, made by Mylan (Viatris)
• Ritonavir boosts and sustains Atazanavir blood levels
• Once-daily dosing as part of combination ART
• Used in both treatment-naive and treatment-experienced patients
• Strip of 30 tablets, Schedule H prescription drug

Composition

• Atazanavir (300mg) + Ritonavir (100mg)

Uses & Benefits

• Used in combination with other antiretrovirals for HIV-1 infection
• Helps maintain effective drug levels through Ritonavir boosting
• Supports long-term suppression of HIV viral load
• Prescribed as part of a structured, physician-supervised regimen

Directions for Use

• Take exactly as prescribed by your physician, alongside other prescribed antiretrovirals
• Usually taken once daily with food
• Swallow the tablet whole with water
• Do not skip doses to help prevent drug resistance

Precautions

• Use only under the supervision of a qualified physician
• Inform your doctor of any kidney or liver conditions before starting treatment
• Regular monitoring of blood counts, liver and kidney function may be required
• Inform your healthcare provider about all other medications you are taking
• Consult your doctor before use during pregnancy or breastfeeding
• Do not skip or stop doses without medical advice, as this may lead to drug resistance

Storage

• Store below 30°C in a cool, dry place
• Keep out of reach of children
• Protect from excessive heat and moisture

Disclaimer

This is a Schedule H prescription medicine. This information is for general awareness and is not a substitute for professional medical advice, diagnosis or treatment. Do not start, stop or change the dose without consulting a qualified healthcare provider.